Immunotherapy & Oncology
Cancer treatment has moved from poisoning dividing cells towards directing the immune system at the tumour, and towards drugs that carry their payload only to cancerous tissue. It absorbs more drug development spending than any other area.
388 stocks
| # | Name | Holding | Trade Value |
Theme Stocks |
% of Portfolio | Status | |
|---|---|---|---|---|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
| $172B | +$1.38B | 205 | 3.1% | Increased |
|
| 2 |
BlackRock
New York
| $153B | +$1.4B | 229 | 3.21% | Increased |
|
| 3 |
State Street
Boston,
Massachusetts
| $87.5B | -$142M | 199 | 3.6% | Reduced |
|
| 4 |
Geode Capital Management
Boston,
Massachusetts
| $40.9B | +$863M | 246 | 3.22% | Increased |
|
| 5 |
JP Morgan Chase
New York
| $39.2B | +$3.97B | 212 | 2.87% | Increased |
|
| 6 |
Fidelity Investments
Boston,
Massachusetts
| $37.3B | +$2.16B | 164 | 2.38% | Increased |
|
| 7 |
Morgan Stanley
New York
| $36.7B | +$960M | 253 | 2.62% | Increased |
|
| 8 |
Wellington Management Group
Boston,
Massachusetts
| $25.7B | -$1.5B | 79 | 4.94% | Reduced |
|
| 9 |
Bank of America
Charlotte,
North Carolina
| $24.7B | +$2.69B | 253 | 1.99% | Increased |
|
| 10 |
Charles Schwab
San Francisco,
California
| $24.2B | -$774M | 135 | 4.53% | Reduced |
|
| 11 |
Norges Bank
Oslo,
Norway
| $23.5B | -$94M | 39 | 3.3% | Reduced |
|
| 12 |
Northern Trust
Chicago,
Illinois
| $21.8B | -$11M | 201 | 3.23% | Reduced |
|
| 13 |
Capital International Investors
Los Angeles,
California
| $20.8B | -$1.2B | 13 | 4.1% | Reduced |
|
| 14 |
T. Rowe Price Associates
Baltimore,
Maryland
| $18.4B | -$316M | 120 | 2.27% | Reduced |
|
| 15 |
Capital World Investors
Los Angeles,
California
| $17.9B | -$657M | 14 | 2.9% | Reduced |
|
| 16 |
Bank of New York Mellon
New York
| $15.9B | +$603M | 136 | 3.16% | Increased |
|
| 17 |
Capital Research Global Investors
Los Angeles,
California
| $15.8B | -$666M | 13 | 3.43% | Reduced |
|
| 18 |
Franklin Resources
San Mateo,
California
| $15.3B | +$872M | 76 | 4.41% | Increased |
|
| 19 |
UBS AM
Chicago,
Illinois
| $14.2B | +$594M | 71 | 3.65% | Increased |
|
| 20 |
Goldman Sachs
New York
| $13.4B | +$780M | 164 | 2.17% | Increased |
|
| 21 |
Invesco
Atlanta,
Georgia
| $12.9B | +$485M | 118 | 2.45% | Increased |
|
| 22 |
Dimensional Fund Advisors
Austin,
Texas
| $12.6B | +$262M | 118 | 3.14% | Increased |
|
| 23 |
Primecap Management
Pasadena,
California
| $12.4B | -$256M | 19 | 10.25% | Reduced |
|
| 24 |
Legal & General Group
London,
United Kingdom
| $12.4B | +$53.8M | 128 | 3.37% | Increased |
|
| 25 |
UBS Group
Zurich,
Switzerland
| $11.5B | -$10.5M | 271 | 2.12% | Reduced |
|